{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:55:13Z","timestamp":1793890513721,"version":"4.8.0"},"reference-count":182,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T00:00:00Z","timestamp":1630886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T00:00:00Z","timestamp":1630886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001711","name":"schweizerischer nationalfonds zur f\u00f6rderung der wissenschaftlichen forschung","doi-asserted-by":"publisher","award":["310030-159999"],"award-info":[{"award-number":["310030-159999"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"name":"soci\u00e9t\u00e9 de rhumatologe"},{"DOI":"10.13039\/501100006389","name":"Universit\u00e9 de Gen\u00e8ve","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006389","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>From the clinical standpoint, systemic sclerosis (SSc) is characterized by skin and internal organ fibrosis, diffuse fibroproliferative vascular modifications, and autoimmunity. Clinical presentation and course are highly heterogenous and life expectancy variably affected mostly dependent on lung and heart involvement. SSc touches more women than men with differences in disease severity and environmental exposure. Pathogenetic events originate from altered homeostasis favored by genetic predisposition, environmental cues and a variety of endogenous and exogenous triggers. Epigenetic modifications modulate SSc pathogenesis which strikingly associate profound immune-inflammatory dysregulation, abnormal endothelial cell behavior, and cell trans-differentiation into myofibroblasts. SSc myofibroblasts show enhanced survival and enhanced extracellular matrix deposition presenting altered structure and altered physicochemical properties. Additional cell types of likely pathogenic importance are pericytes, platelets, and keratinocytes in conjunction with their relationship with vessel wall cells and fibroblasts. In SSc, the profibrotic milieu is favored by cell signaling initiated in the one hand by transforming growth factor-beta and related cytokines and in the other hand by innate and adaptive type 2 immune responses. Radical oxygen species and invariant receptors sensing danger participate to altered cell behavior. Conventional and SSc-specific T cell subsets modulate both fibroblasts as well as endothelial cell dysfunction. Beside autoantibodies directed against ubiquitous antigens important for enhanced clinical classification, antigen-specific agonistic autoantibodies may have a pathogenic role. Recent studies based on single-cell RNAseq and multi-omics approaches are revealing unforeseen heterogeneity in SSc cell differentiation and functional states. Advances in system biology applied to the wealth of data generated by unbiased screening are allowing to subgroup patients based on distinct pathogenic mechanisms. Deciphering heterogeneity in pathogenic mechanisms will pave the way to highly needed personalized therapeutic approaches.<\/jats:p>","DOI":"10.1007\/s12016-021-08889-8","type":"journal-article","created":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T13:02:58Z","timestamp":1630933378000},"page":"262-283","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":169,"title":["Current Concepts on the Pathogenesis of Systemic Sclerosis"],"prefix":"10.1007","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8045-0180","authenticated-orcid":false,"given":"Marie Elise","family":"Truchetet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1591-1790","authenticated-orcid":false,"given":"Nicol\u00f2 C.","family":"Brembilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4849-6335","authenticated-orcid":false,"given":"Carlo","family":"Chizzolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,6]]},"reference":[{"key":"8889_CR1","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/s0140-6736(17)30933-9","volume":"390","author":"CP Denton","year":"2017","unstructured":"Denton CP, Khanna D (2017) Systemic sclerosis. Lancet 390:1685\u20131699. https:\/\/doi.org\/10.1016\/s0140-6736(17)30933-9","journal-title":"Lancet."},{"key":"8889_CR2","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","volume":"76","author":"M Elhai","year":"2017","unstructured":"Elhai M, Meune C, Boubaya M, Avouac J, Hachulla E, Balbir-Gurman A, Riemekasten G, Airo P, Joven B, Vettori S, Cozzi F, Ullman S, Czirjak L, Tikly M, Muller-Ladner U, Caramaschi P, Distler O, Iannone F, Ananieva LP, Hesselstrand R, Becvar R, Gabrielli A, Damjanov N, Salvador MJ, Riccieri V, Mihai C, Szucs G, Walker UA, Hunzelmann N, Martinovic D, Smith V, Muller CS, Montecucco CM, Opris D, Ingegnoli F, Vlachoyiannopoulos PG, Stamenkovic B, Rosato E, Heitmann S, Distler JHW, Zenone T, Seidel M, Vacca A, Langhe E, Novak S, Cutolo M, Mouthon L, Henes J, Chizzolini C, Muhlen CAV, Solanki K, Rednic S, Stamp L, Anic B, Santamaria VO, De Santis M, Yavuz S, Sifuentes-Giraldo WA, Chatelus E, Stork J, Laar JV, Loyo E, de la Pena Garcia, Lefebvre P, Eyerich K, Cosentino V, Alegre-Sancho JJ, Kowal-Bielecka O, Rey G, Matucci-Cerinic M, Allanore Y (2017) Mapping and predicting mortality from systemic sclerosis. Ann Rheum Dis 76:1897\u20131905. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211448","journal-title":"Ann Rheum Dis."},{"key":"8889_CR3","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.rdc.2020.07.009","volume":"46","author":"DF Moore","year":"2020","unstructured":"Moore DF, Steen VD (2020) Racial disparities in systemic sclerosis. Rheum Dis Clin North Am 46:705\u2013712. https:\/\/doi.org\/10.1016\/j.rdc.2020.07.009","journal-title":"Rheum Dis Clin North Am."},{"key":"8889_CR4","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.it.2005.09.004","volume":"26","author":"DJ Abraham","year":"2005","unstructured":"Abraham DJ, Varga J (2005) Scleroderma: from cell and molecular mechanisms to disease models. Trends Immunol 26:587\u2013595","journal-title":"Trends Immunol."},{"key":"8889_CR5","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1146\/annurev-pathol-011110-130312","volume":"6","author":"TR Katsumoto","year":"2011","unstructured":"Katsumoto TR, Whitfield ML, Connolly MK (2011) The pathogenesis of systemic sclerosis. Ann Rev Pathol 6:509\u2013537. https:\/\/doi.org\/10.1146\/annurev-pathol-011110-130312","journal-title":"Annual review of pathology."},{"key":"8889_CR6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.rdc.2015.04.002","volume":"41","author":"EP Stern","year":"2015","unstructured":"Stern EP, Denton CP (2015) The pathogenesis of systemic sclerosis. Rheum Dis Clin North Am 41:367\u2013382. https:\/\/doi.org\/10.1016\/j.rdc.2015.04.002","journal-title":"Rheum Dis Clin North Am."},{"key":"8889_CR7","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.autrev.2016.03.005","volume":"15","author":"O Cabral-Marques","year":"2016","unstructured":"Cabral-Marques O, Riemekasten G (2016) Vascular hypothesis revisited: role of stimulating antibodies against angiotensin and endothelin receptors in the pathogenesis of systemic sclerosis. Autoimmun Rev 15:690\u2013694. https:\/\/doi.org\/10.1016\/j.autrev.2016.03.005","journal-title":"Autoimmun Rev."},{"key":"8889_CR8","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2217\/epi-2016-0150","volume":"9","author":"C Bergmann","year":"2017","unstructured":"Bergmann C, Distler JH (2017) Epigenetic factors as drivers of fibrosis in systemic sclerosis. Epigenomics 9:463\u2013477. https:\/\/doi.org\/10.2217\/epi-2016-0150","journal-title":"Epigenomics."},{"key":"8889_CR9","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.3389\/fimmu.2018.03112","volume":"9","author":"ATJ Maria","year":"2018","unstructured":"Maria ATJ, Partouche L, Goulabchand R, Rivi\u00e8re S, Rozier P, Bourgier C, Le Quellec A, Morel J, No\u00ebl D, Guilpain P (2018) Intriguing relationships between cancer and systemic sclerosis: role of the immune system and other contributors. Front Immunol 9:3112. https:\/\/doi.org\/10.3389\/fimmu.2018.03112","journal-title":"Frontiers in immunology."},{"key":"8889_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101122","volume":"25","author":"L Doridot","year":"2019","unstructured":"Doridot L, Jeljeli M, Ch\u00eane C, Batteux F (2019) Implication of oxidative stress in the pathogenesis of systemic sclerosis via inflammation, autoimmunity and fibrosis. Redox Biol 25:101122. https:\/\/doi.org\/10.1016\/j.redox.2019.101122","journal-title":"Redox biology."},{"key":"8889_CR11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.metabol.2018.12.004","volume":"93","author":"H Zhu","year":"2019","unstructured":"Zhu H, Chen W, Liu D, Luo H (2019) The role of metabolism in the pathogenesis of systemic sclerosis. Metabolism 93:44\u201351. https:\/\/doi.org\/10.1016\/j.metabol.2018.12.004","journal-title":"Metabolism."},{"key":"8889_CR12","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41584-019-0212-z","volume":"15","author":"G Kania","year":"2019","unstructured":"Kania G, Rudnik M, Distler O (2019) Involvement of the myeloid cell compartment in fibrogenesis and systemic sclerosis. Nat Rev Rheumatol 15:288\u2013302. https:\/\/doi.org\/10.1038\/s41584-019-0212-z","journal-title":"Nature Reviews Rheumatology."},{"key":"8889_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2019.101474","volume":"34","author":"AL Herrick","year":"2020","unstructured":"Herrick AL, Wigley FM (2020) Raynaud\u2019s phenomenon. Best Pract Res Clin Rheumatol 34:101474. https:\/\/doi.org\/10.1016\/j.berh.2019.101474","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"8889_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.rdc.2007.10.001","volume":"34","author":"SK Agarwal","year":"2008","unstructured":"Agarwal SK, Tan FK, Arnett FC (2008) Genetics and genomic studies in scleroderma (systemic sclerosis). Rheum Dis Clin N Am 34:17\u201340. https:\/\/doi.org\/10.1016\/j.rdc.2007.10.001","journal-title":"Rheumatic Disease Clinics of North America."},{"key":"8889_CR15","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1002\/1529-0131(200107)44:7<1654::AID-ART288>3.0.CO;2-O","volume":"44","author":"M Kuwana","year":"2001","unstructured":"Kuwana M, Feghali CA, Medsger TA Jr, Wright TM (2001) Autoreactive T cells to topoisomerase I in monozygotic twins discordant for systemic sclerosis. Arthritis Rheum 44:1654\u20131659","journal-title":"Arthritis Rheum."},{"key":"8889_CR16","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1002\/art.11173","volume":"48","author":"C Feghali-Bostwick","year":"2003","unstructured":"Feghali-Bostwick C, Medsger TA Jr, Wright TM (2003) Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. Arthritis Rheum 48:1956\u20131963. https:\/\/doi.org\/10.1002\/art.11173","journal-title":"Arthritis Rheum."},{"key":"8889_CR17","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1136\/ard.2009.111906","volume":"69","author":"FC Arnett","year":"2010","unstructured":"Arnett FC, Gourh P, Shete S, Ahn CW, Honey RE, Agarwal SK, Tan FK, McNearney T, Fischbach M, Fritzler MJ, Mayes MD, Reveille JD (2010) Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls. Ann Rheum Dis 69:822\u2013827. https:\/\/doi.org\/10.1136\/ard.2009.111906","journal-title":"Ann Rheum Dis."},{"key":"8889_CR18","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1073\/pnas.1906593116","volume":"117","author":"P Gourh","year":"2020","unstructured":"Gourh P, Safran SA, Alexander T, Boyden SE, Morgan ND, Shah AA, Mayes MD, Doumatey A, Bentley AR, Shriner D, Domsic RT, Medsger TA Jr, Ramos PS, Silver RM, Steen VD, Varga J, Hsu V, Saketkoo LA, Schiopu E, Khanna D, Gordon JK, Kron B, Criswell LA, Gladue H, Derk CT, Bernstein EJ, Bridges SL Jr, Shanmugam VK, Kolstad KD, Chung L, Kafaja S, Jan R, Trojanowski M, Goldberg A, Korman BD, Steinbach PJ, Chandrasekharappa SC, Mullikin JC, Adeyemo A, Rotimi C, Wigley FM, Kastner DL, Boin F, Remmers EF (2020) HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry. Proc Natl Acad Sci U S A 117:552\u2013562. https:\/\/doi.org\/10.1073\/pnas.1906593116","journal-title":"Proc Natl Acad Sci U S A."},{"key":"8889_CR19","doi-asserted-by":"publisher","first-page":"4955","DOI":"10.1038\/s41467-019-12760-y","volume":"10","author":"E L\u00f3pez-Isac","year":"2019","unstructured":"L\u00f3pez-Isac E, Acosta-Herrera M, Kerick M, Assassi S, Satpathy AT, Granja J, Mumbach MR, Beretta L, Sime\u00f3n CP, Carreira P, Ortego-Centeno N, Castellvi I, Bossini-Castillo L, Carmona FD, Orozco G, Hunzelmann N, Distler JHW, Franke A, Lunardi C, Moroncini G, Gabrielli A, de Vries-Bouwstra J, Wijmenga C, Koeleman BPC, Nordin A, Padyukov L, Hoffmann-Vold AM, Lie B, Proudman S, Stevens W, Nikpour M, Vyse T, Herrick AL, Worthington J, Denton CP, Allanore Y, Brown MA, Radstake T, Fonseca C, Chang HY, Mayes MD, Martin J (2019) GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways. Nat Commun 10:4955. https:\/\/doi.org\/10.1038\/s41467-019-12760-y","journal-title":"Nature communications."},{"key":"8889_CR20","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/bor.0000000000000735","volume":"32","author":"C Orvain","year":"2020","unstructured":"Orvain C, Assassi S, Avouac J, Allanore Y (2020) Systemic sclerosis pathogenesis: contribution of recent advances in genetics. Curr Opin Rheumatol 32:505\u2013514. https:\/\/doi.org\/10.1097\/bor.0000000000000735","journal-title":"Curr Opin Rheumatol."},{"key":"8889_CR21","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1136\/annrheumdis-2014-205303","volume":"74","author":"N Altorok","year":"2015","unstructured":"Altorok N, Tsou PS, Coit P, Khanna D, Sawalha AH (2015) Genome-wide DNA methylation analysis in dermal fibroblasts from patients with diffuse and limited systemic sclerosis reveals common and subset-specific DNA methylation aberrancies. Ann Rheum Dis 74:1612\u20131620. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205303","journal-title":"Ann Rheum Dis."},{"key":"8889_CR22","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1136\/annrheumdis-2012-203194","volume":"73","author":"C Dees","year":"2014","unstructured":"Dees C, Schlottmann I, Funke R, Distler A, Palumbo-Zerr K, Zerr P, Lin NY, Beyer C, Distler O, Schett G, Distler JH (2014) The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis. Ann Rheum Dis 73:1232\u20131239. https:\/\/doi.org\/10.1136\/annrheumdis-2012-203194","journal-title":"Ann Rheum Dis."},{"key":"8889_CR23","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1002\/art.27443","volume":"62","author":"B Maurer","year":"2010","unstructured":"Maurer B, Stanczyk J, J\u00fcngel A, Akhmetshina A, Trenkmann M, Brock M, Kowal-Bielecka O, Gay RE, Michel BA, Distler JH, Gay S, Distler O (2010) MicroRNA-29, a key regulator of collagen expression in systemic sclerosis. Arthritis Rheum 62:1733\u20131743. https:\/\/doi.org\/10.1002\/art.27443","journal-title":"Arthritis Rheum."},{"key":"8889_CR24","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1093\/rheumatology\/kes120","volume":"51","author":"T Sing","year":"2012","unstructured":"Sing T, Jinnin M, Yamane K, Honda N, Makino K, Kajihara I, Makino T, Sakai K, Masuguchi S, Fukushima S, Ihn H (2012) microRNA-92a expression in the sera and dermal fibroblasts increases in patients with scleroderma. Rheumatology (Oxford) 51:1550\u20131556. https:\/\/doi.org\/10.1093\/rheumatology\/kes120","journal-title":"Rheumatology (Oxford)."},{"key":"8889_CR25","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.3899\/jrheum.090207","volume":"36","author":"GF Mora","year":"2009","unstructured":"Mora GF (2009) Systemic sclerosis: environmental factors. J Rheumatol 36:2383\u20132396. https:\/\/doi.org\/10.3899\/jrheum.090207","journal-title":"J Rheumatol."},{"key":"8889_CR26","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jaut.2012.05.002","volume":"39","author":"FW Miller","year":"2012","unstructured":"Miller FW, Alfredsson L, Costenbader KH, Kamen DL, Nelson LM, Norris JM, De Roos AJ (2012) Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop. J Autoimmun 39:259\u2013271. https:\/\/doi.org\/10.1016\/j.jaut.2012.05.002","journal-title":"J Autoimmun."},{"key":"8889_CR27","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.autrev.2018.11.001","volume":"18","author":"I Marie","year":"2019","unstructured":"Marie I (2019) Systemic sclerosis and exposure to heavy metals. Autoimmun Rev 18:62\u201372. https:\/\/doi.org\/10.1016\/j.autrev.2018.11.001","journal-title":"Autoimmun Rev."},{"key":"8889_CR28","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10067-016-3533-1","volume":"36","author":"M Rubio-Rivas","year":"2017","unstructured":"Rubio-Rivas M, Moreno R, Corbella X (2017) Occupational and environmental scleroderma. Systematic review and meta-analysis. Clin Rheumatol 36:569\u2013582. https:\/\/doi.org\/10.1007\/s10067-016-3533-1","journal-title":"Systematic review and meta-analysis. Clin Rheumatol."},{"key":"8889_CR29","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.semarthrit.2015.06.004","volume":"45","author":"M Freire","year":"2015","unstructured":"Freire M, Alonso M, Rivera A, Sousa A, Soto A, Gomez-Sousa JM, Baroja A, Vazquez-Trinanes C, Sopena B (2015) Clinical peculiarities of patients with scleroderma exposed to silica: A systematic review of the literature. Semin Arthritis Rheum 45:294\u2013300. https:\/\/doi.org\/10.1016\/j.semarthrit.2015.06.004","journal-title":"Semin Arthritis Rheum."},{"key":"8889_CR30","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.autrev.2008.07.022","volume":"8","author":"SB Randone","year":"2008","unstructured":"Randone SB, Guiducci S, Cerinic MM (2008) Systemic sclerosis and infections. Autoimmun Rev 8:36\u201340. https:\/\/doi.org\/10.1016\/j.autrev.2008.07.022","journal-title":"Autoimmun Rev."},{"key":"8889_CR31","first-page":"3","volume":"31","author":"G Moroncini","year":"2013","unstructured":"Moroncini G, Mori S, Tonnini C, Gabrielli A (2013) Role of viral infections in the etiopathogenesis of systemic sclerosis. Clin Exp Rheumatol 31:3\u20137","journal-title":"Clin Exp Rheumatol."},{"key":"8889_CR32","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/80533","volume":"6","author":"C Lunardi","year":"2000","unstructured":"Lunardi C, Bason C, Navone R, Millo E, Damonte G, Corrocher R, Puccetti A (2000) Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nat Med 6:1183\u20131186","journal-title":"Nat Med."},{"key":"8889_CR33","doi-asserted-by":"crossref","unstructured":"Lunardi C, Dolcino M, Peterlana D, Bason C, Navone R, Tamassia N, Beri R, Corrocher R, Puccetti A (2006) Antibodies against human cytomegalovirus in the pathogenesis of systemic sclerosis: a gene array approach. PLoS Med 3:e2","DOI":"10.1371\/journal.pmed.0030002"},{"key":"8889_CR34","first-page":"718","volume":"17","author":"C Ferri","year":"1999","unstructured":"Ferri C, Zakrzewska K, Longombardo G, Giuggioli D, Storino FA, Pasero G, Azzi A (1999) Parvovirus B19 infection of bone marrow in systemic sclerosis patients. Clin Exp Rheumatol 17:718\u2013720","journal-title":"Clin Exp Rheumatol."},{"key":"8889_CR35","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1093\/rheumatology\/keaa230","volume":"59","author":"R Arvia","year":"2020","unstructured":"Arvia R, Margheri F, Stincarelli MA, Laurenzana A, Fibbi G, Gallinella G, Ferri C, Del Rosso M, Zakrzewska K (2020) Parvovirus B19 activates in vitro normal human dermal fibroblasts: a possible implication in skin fibrosis and systemic sclerosis. Rheumatology (Oxford) 59:3526\u20133532. https:\/\/doi.org\/10.1093\/rheumatology\/keaa230","journal-title":"Rheumatology (Oxford)."},{"key":"8889_CR36","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/jid.2013.423","volume":"134","author":"A Farina","year":"2014","unstructured":"Farina A, Cirone M, York M, Lenna S, Padilla C, McLaughlin S, Faggioni A, Lafyatis R, Trojanowska M, Farina GA (2014) Epstein-Barr virus infection induces aberrant TLR activation pathway and fibroblast-myofibroblast conversion in scleroderma. J Invest Dermatol 134:954\u2013964. https:\/\/doi.org\/10.1038\/jid.2013.423","journal-title":"J Invest Dermatol."},{"key":"8889_CR37","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1002\/art.27549","volume":"62","author":"AA Shah","year":"2010","unstructured":"Shah AA, Rosen A, Hummers L, Wigley F, Casciola-Rosen L (2010) Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I\/III antibodies. Arthritis Rheum 62:2787\u20132795. https:\/\/doi.org\/10.1002\/art.27549","journal-title":"Arthritis Rheum."},{"key":"8889_CR38","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1126\/science.1246886","volume":"343","author":"CG Joseph","year":"2014","unstructured":"Joseph CG, Darrah E, Shah AA, Skora AD, Casciola-Rosen LA, Wigley FM, Boin F, Fava A, Thoburn C, Kinde I, Jiao Y, Papadopoulos N, Kinzler KW, Vogelstein B, Rosen A (2014) Association of the autoimmune disease scleroderma with an immunologic response to cancer. Science 343:152\u2013157. https:\/\/doi.org\/10.1126\/science.1246886","journal-title":"Science."},{"key":"8889_CR39","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S0140-6736(97)08357-8","volume":"351","author":"JL Nelson","year":"1998","unstructured":"Nelson JL, Furst DE, Maloney S, Gooley T, Evans PC, Smith A, Bean MA, Ober C, Bianchi DW (1998) Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 351:559\u2013562","journal-title":"Lancet."},{"key":"8889_CR40","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/art.10049","volume":"46","author":"C Scaletti","year":"2002","unstructured":"Scaletti C, Vultaggio A, Bonifacio S, Emmi L, Torricelli F, Maggi E, Romagnani S, Piccinni MP (2002) Th2-oriented profile of male offspring T cells present in women with systemic sclerosis and reactive with maternal major histocompatibility complex antigens. Arthritis Rheum 46:445\u2013450","journal-title":"Arthritis Rheum."},{"key":"8889_CR41","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1002\/1529-0131(200011)43:11<2598::AID-ANR30>3.0.CO;2-8","volume":"43","author":"PJ Christner","year":"2000","unstructured":"Christner PJ, Artlett CM, Conway RF, Jimenez SA (2000) Increased numbers of microchimeric cells of fetal origin are associated with dermal fibrosis in mice following injection of vinyl chloride. Arthritis Rheum 43:2598\u20132605","journal-title":"Arthritis Rheum."},{"key":"8889_CR42","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jaut.2009.03.005","volume":"33","author":"P Invernizzi","year":"2009","unstructured":"Invernizzi P, Pasini S, Selmi C, Gershwin ME, Podda M (2009) Female predominance and X chromosome defects in autoimmune diseases. J Autoimmun 33:12\u201316. https:\/\/doi.org\/10.1016\/j.jaut.2009.03.005","journal-title":"J Autoimmun."},{"key":"8889_CR43","doi-asserted-by":"publisher","first-page":"177","DOI":"10.5301\/jsrd.5000209","volume":"1","author":"C Peoples","year":"2016","unstructured":"Peoples C, Medsger TA Jr, Lucas M, Rosario BL, Feghali-Bostwick CA (2016) Gender differences in systemic sclerosis: relationship to clinical features, serologic status and outcomes. J Scleroderma Relat Disord 1:177\u2013240. https:\/\/doi.org\/10.5301\/jsrd.5000209","journal-title":"J Scleroderma Relat Disord."},{"key":"8889_CR44","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13023-021-01733-4","volume":"16","author":"A Coi","year":"2021","unstructured":"Coi A, Barsotti S, Santoro M, Almerigogna F, Bargagli E, Caproni M, Emmi G, Frediani B, Guiducci S, Matucci Cerinic M, Mosca M, Parronchi P, Prediletto R, Selvi E, Simonini G, Tavoni AG, Bianchi F, Pierini A (2021) Epidemiology of systemic sclerosis: a multi-database population-based study in Tuscany (Italy). Orphanet J Rare Dis 16:90. https:\/\/doi.org\/10.1186\/s13023-021-01733-4","journal-title":"Orphanet journal of rare diseases."},{"key":"8889_CR45","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/annrheumdis-2014-206386","volume":"75","author":"M Elhai","year":"2016","unstructured":"Elhai M, Avouac J, Walker UA, Matucci-Cerinic M, Riemekasten G, Air\u00f2 P, Hachulla E, Valentini G, Carreira PE, Cozzi F, Balbir Gurman A, Braun-Moscovici Y, Damjanov N, Ananieva LP, Scorza R, Jimenez S, Busquets J, Li M, M\u00fcller-Ladner U, Kahan A, Distler O, Allanore Y (2016) A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study. Ann Rheum Dis 75:163\u2013169. https:\/\/doi.org\/10.1136\/annrheumdis-2014-206386","journal-title":"Ann Rheum Dis."},{"issue":"Suppl 113","key":"8889_CR46","first-page":"68","volume":"36","author":"PE Carreira","year":"2018","unstructured":"Carreira PE, Carmona L, Joven BE, Loza E, Andreu JL, Riemekasten G, Vettori S, Balbir-Gurman A, Air\u00f2 P, Walker UA, Damjanov N, Matucci-Cerinic M, Ananieva LP, Rednic S, Czirj\u00e1k L, Distler O, Farge D, Hesselstrand R, Corrado A, Caramaschi P, Tikly M, Allanore Y (2018) Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) database. Clin Exp Rheumatol. 36(Suppl 113):68\u201375","journal-title":"Clin Exp Rheumatol."},{"key":"8889_CR47","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3389\/fimmu.2018.00794","volume":"9","author":"MR Gubbels Bupp","year":"2018","unstructured":"Gubbels Bupp MR, Jorgensen TN (2018) Androgen-induced immunosuppression. Front Immunol 9:794. https:\/\/doi.org\/10.3389\/fimmu.2018.00794","journal-title":"Androgen-induced immunosuppression. Frontiers in immunology."},{"key":"8889_CR48","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.3389\/fimmu.2018.01332","volume":"9","author":"O Bereshchenko","year":"2018","unstructured":"Bereshchenko O, Bruscoli S, Riccardi C (2018) Glucocorticoids, sex hormones, and immunity. Front Immunol 9:1332. https:\/\/doi.org\/10.3389\/fimmu.2018.01332","journal-title":"Frontiers in immunology."},{"key":"8889_CR49","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41584-020-0503-4","volume":"16","author":"M Cutolo","year":"2020","unstructured":"Cutolo M, Straub RH (2020) Sex steroids and autoimmune rheumatic diseases: state of the art. Nat Rev Rheumatol 16:628\u2013644. https:\/\/doi.org\/10.1038\/s41584-020-0503-4","journal-title":"Nat Rev Rheumatol."},{"key":"8889_CR50","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.semarthrit.2019.07.007","volume":"50","author":"J Ciaffi","year":"2020","unstructured":"Ciaffi J, van Leeuwen NM, Schoones JW, Huizinga TWJ, de Vries-Bouwstra JK (2020) Sex hormones and sex hormone-targeting therapies in systemic sclerosis: A systematic literature review. Semin Arthritis Rheum 50:140\u2013148. https:\/\/doi.org\/10.1016\/j.semarthrit.2019.07.007","journal-title":"Semin Arthritis Rheum."},{"key":"8889_CR51","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/379131a0","volume":"379","author":"GD Penny","year":"1996","unstructured":"Penny GD, Kay GF, Sheardown SA, Rastan S, Brockdorff N (1996) Requirement for Xist in X chromosome inactivation. Nature 379:131\u2013137. https:\/\/doi.org\/10.1038\/379131a0","journal-title":"Nature."},{"key":"8889_CR52","doi-asserted-by":"publisher","unstructured":"Youness A, Miquel CH, Gu\u00e9ry JC (2021) Escape from X Chromosome Inactivation and the Female Predominance in Autoimmune Diseases. Int J Mol Sci 22.\u00a0https:\/\/doi.org\/10.3390\/ijms22031114","DOI":"10.3390\/ijms22031114"},{"key":"8889_CR53","doi-asserted-by":"publisher","unstructured":"Souyris M, Cenac C, Azar P, Daviaud D, Canivet A, Grunenwald S, Pienkowski C, Chaumeil J, Mej\u00eda JE, Gu\u00e9ry JC (2018) TLR7 escapes X chromosome inactivation in immune cells. Sci Immunol 3.\u00a0https:\/\/doi.org\/10.1126\/sciimmunol.aap8855","DOI":"10.1126\/sciimmunol.aap8855"},{"key":"8889_CR54","doi-asserted-by":"publisher","first-page":"575","DOI":"10.4049\/jimmunol.175.1.575","volume":"175","author":"P Invernizzi","year":"2005","unstructured":"Invernizzi P, Miozzo M, Selmi C, Persani L, Battezzati PM, Zuin M, Lucchi S, Meroni PL, Marasini B, Zeni S, Watnik M, Grati FR, Simoni G, Gershwin ME, Podda M (2005) X chromosome monosomy: a common mechanism for autoimmune diseases. J Immunol 175:575\u2013578. https:\/\/doi.org\/10.4049\/jimmunol.175.1.575","journal-title":"J Immunol."},{"key":"8889_CR55","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1365-2249.2012.04621.x","volume":"169","author":"C Selmi","year":"2012","unstructured":"Selmi C, Feghali-Bostwick CA, Lleo A, Lombardi SA, De Santis M, Cavaciocchi F, Zammataro L, Mitchell MM, Lasalle JM, Medsger T Jr, Gershwin ME (2012) X chromosome gene methylation in peripheral lymphocytes from monozygotic twins discordant for scleroderma. Clin Exp Immunol 169:253\u2013262. https:\/\/doi.org\/10.1111\/j.1365-2249.2012.04621.x","journal-title":"Clin Exp Immunol."},{"key":"8889_CR56","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1136\/ard.2010.129999","volume":"69","author":"JC Broen","year":"2010","unstructured":"Broen JC, Wolvers-Tettero IL, Geurts-van Bon L, Vonk MC, Coenen MJ, Lafyatis R, Radstake TR, Langerak AW (2010) Skewed X chromosomal inactivation impacts T regulatory cell function in systemic sclerosis. Ann Rheum Dis 69:2213\u20132216. https:\/\/doi.org\/10.1136\/ard.2010.129999","journal-title":"Ann Rheum Dis."},{"key":"8889_CR57","first-page":"2015","volume":"33","author":"B Granel","year":"2006","unstructured":"Granel B, Allanore Y, Chevillard C, Arnaud V, Marquet S, Weiller PJ, Durand JM, Harl\u00e9 JR, Grange C, Frances Y, Berbis P, Gaudart J, de Micco P, Kahan A, Dessein A (2006) IL13RA2 gene polymorphisms are associated with systemic sclerosis. J Rheumatol 33:2015\u20132019","journal-title":"J Rheumatol."},{"key":"8889_CR58","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1002\/art.30640","volume":"63","author":"P Dieud\u00e9","year":"2011","unstructured":"Dieud\u00e9 P, Bouaziz M, Guedj M, Riemekasten G, Air\u00f2 P, M\u00fcller M, Cusi D, Matucci-Cerinic M, Melchers I, Koenig W, Salvi E, Wichmann HE, Cuomo G, Hachulla E, Diot E, Hunzelmann N, Caramaschi P, Mouthon L, Riccieri V, Distler J, Tarner I, Avouac J, Meyer O, Kahan A, Chiocchia G, Boileau C, Allanore Y (2011) Evidence of the contribution of the X chromosome to systemic sclerosis susceptibility: association with the functional IRAK1 196Phe\/532Ser haplotype. Arthritis Rheum 63:3979\u20133987. https:\/\/doi.org\/10.1002\/art.30640","journal-title":"Arthritis Rheum."},{"key":"8889_CR59","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1136\/annrheumdis-2012-202742","volume":"72","author":"FD Carmona","year":"2013","unstructured":"Carmona FD, C\u00e9nit MC, Diaz-Gallo LM, Broen JC, Sime\u00f3n CP, Carreira PE, Callejas-Rubio JL, Fonollosa V, L\u00f3pez-Longo FJ, Gonz\u00e1lez-Gay MA, Hunzelmann N, Riemekasten G, Witte T, Kreuter A, Distler JH, Madhok R, Shiels P, van Laar JM, Schuerwegh AJ, Vonk MC, Voskuyl AE, Fonseca C, Denton CP, Herrick A, Worthington J, Arnett FC, Tan FK, Assassi S, Radstake TR, Mayes MD, Mart\u00edn J (2013) New insight on the Xq28 association with systemic sclerosis. Ann Rheum Dis 72:2032\u20132038. https:\/\/doi.org\/10.1136\/annrheumdis-2012-202742","journal-title":"Ann Rheum Dis."},{"key":"8889_CR60","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.imbio.2017.10.004","volume":"223","author":"F D'Amico","year":"2018","unstructured":"D\u2019Amico F, Fiorito G, Skarmoutsou E, Granata M, Rossi GA, Trovato C, Bellocchi C, Marchini M, Beretta L, Mazzarino MC (2018) FOXP3, ICOS and ICOSL gene polymorphisms in systemic sclerosis: FOXP3 rs2294020 is associated with disease progression in a female Italian population. Immunobiology 223:112\u2013117. https:\/\/doi.org\/10.1016\/j.imbio.2017.10.004","journal-title":"Immunobiology."},{"key":"8889_CR61","doi-asserted-by":"publisher","unstructured":"Fioretto BS, Rosa I, Romano E, Wang Y, Guiducci S, Zhang G, Manetti M, Matucci-Cerinic M (2020) The contribution of epigenetics to the pathogenesis and gender dimorphism of systemic sclerosis: a comprehensive overview. Ther Adv Musculoskelet Dis. 12: 1759720x20918456. https:\/\/doi.org\/10.1177\/1759720x20918456","DOI":"10.1177\/1759720x20918456"},{"key":"8889_CR62","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1002\/art.37988","volume":"65","author":"M Matucci-Cerinic","year":"2013","unstructured":"Matucci-Cerinic M, Kahaleh B, Wigley FM (2013) Review: evidence that systemic sclerosis is a vascular disease. Arthritis Rheum 65:1953\u20131962. https:\/\/doi.org\/10.1002\/art.37988","journal-title":"Arthritis Rheum."},{"key":"8889_CR63","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1172\/jci118851","volume":"98","author":"R Sgonc","year":"1996","unstructured":"Sgonc R, Gruschwitz MS, Dietrich H, Recheis H, Gershwin ME, Wick G (1996) Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma. J Clin Invest 98:785\u2013792. https:\/\/doi.org\/10.1172\/jci118851","journal-title":"J Clin Invest."},{"key":"8889_CR64","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1002\/1529-0131(200011)43:11<2550::AID-ANR24>3.0.CO;2-H","volume":"43","author":"R Sgonc","year":"2000","unstructured":"Sgonc R, Gruschwitz MS, Boeck G, Sepp N, Gruber J, Wick G (2000) Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95. Arthritis Rheum 43:2550\u20132562","journal-title":"Arthritis Rheum."},{"key":"8889_CR65","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/1529-0131(199802)41:2<327::AID-ART17>3.0.CO;2-S","volume":"41","author":"R Giacomelli","year":"1998","unstructured":"Giacomelli R, Matucci-Cerinic M, Cipriani P, Ghersetich I, Lattanzio R, Pavan A, Pignone A, Cagnoni ML, Lotti T, Tonietti G (1998) Circulating Vdelta1+ T cells are activated and accumulate in the skin of systemic sclerosis patients. Arthritis Rheum 41:327\u2013334","journal-title":"Arthritis Rheum."},{"key":"8889_CR66","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.3389\/fimmu.2018.01665","volume":"9","author":"A Benyamine","year":"2018","unstructured":"Benyamine A, Magalon J, Sabatier F, Lyonnet L, Robert S, Dumoulin C, Morange S, Mazodier K, Kaplanski G, Reynaud-Gaubert M, Rossi P, Dignat-George F, Granel B, Paul P (2018) Natural Killer Cells Exhibit a Peculiar Phenotypic Profile in Systemic Sclerosis and Are Potent Inducers of Endothelial Microparticles Release. Front Immunol 9:1665. https:\/\/doi.org\/10.3389\/fimmu.2018.01665","journal-title":"Frontiers in immunology."},{"key":"8889_CR67","doi-asserted-by":"publisher","DOI":"10.1172\/JCI131700","author":"T Maehara","year":"2020","unstructured":"Maehara T, Kaneko N, Perugino CA, Mattoo H, Kers J, Allard-Chamard H, Mahajan VS, Liu H, Murphy SJ, Ghebremichael M, Fox DA, Payne AS, Lafyatis R, Stone JH, Khanna D, Pillai S (2020) Cytotoxic CD4+ T lymphocytes may induce endothelial cell apoptosis in systemic sclerosis. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI131700","journal-title":"J Clin Invest"},{"key":"8889_CR68","doi-asserted-by":"publisher","first-page":"3902","DOI":"10.1002\/art.24038","volume":"58","author":"M Koenig","year":"2008","unstructured":"Koenig M, Joyal F, Fritzler MJ, Roussin A, Abrahamowicz M, Boire G, Goulet JR, Rich E, Grodzicky T, Raymond Y, Senecal JL (2008) Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud\u2019s phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum 58:3902\u20133912. https:\/\/doi.org\/10.1002\/art.24038","journal-title":"Arthritis Rheum."},{"key":"8889_CR69","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2017.14506","volume":"147","author":"F Ingegnoli","year":"2017","unstructured":"Ingegnoli F, Ughi N, Crotti C, Mosca M, Tani C (2017) Outcomes, rates and predictors of transition of isolated Raynaud\u2019s phenomenon: a systematic review and meta-analysis. Swiss Med Wkly 147:w14506. https:\/\/doi.org\/10.4414\/smw.2017.14506","journal-title":"Swiss Med Wkly."},{"key":"8889_CR70","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/art.1780270607","volume":"27","author":"AD Roumm","year":"1984","unstructured":"Roumm AD, Whiteside TL, Medsger TA Jr, Rodnan GP (1984) Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations. Arthritis Rheum 27:645\u2013653","journal-title":"Arthritis Rheum."},{"key":"8889_CR71","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/path.1711660307","volume":"166","author":"RJ Prescott","year":"1992","unstructured":"Prescott RJ, Freemont AJ, Jones CJ, Hoyland J, Fielding P (1992) Sequential dermal microvascular and perivascular changes in the development of scleroderma. J Pathol 166:255\u2013263","journal-title":"J Pathol."},{"key":"8889_CR72","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1161\/01.cir.92.6.1448","volume":"92","author":"RR Freedman","year":"1995","unstructured":"Freedman RR, Baer RP, Mayes MD (1995) Blockade of vasospastic attacks by alpha 2-adrenergic but not alpha 1-adrenergic antagonists in idiopathic Raynaud\u2019s disease. Circulation 92:1448\u20131451. https:\/\/doi.org\/10.1161\/01.cir.92.6.1448","journal-title":"Circulation."},{"key":"8889_CR73","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1111\/jcmm.13630","volume":"22","author":"R Vona","year":"2018","unstructured":"Vona R, Giovannetti A, Gambardella L, Malorni W, Pietraforte D, Straface E (2018) Oxidative stress in the pathogenesis of systemic scleroderma: An overview. J Cell Mol Med 22:3308\u20133314. https:\/\/doi.org\/10.1111\/jcmm.13630","journal-title":"J Cell Mol Med."},{"key":"8889_CR74","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.semarthrit.2017.05.004","volume":"47","author":"K Ntelis","year":"2017","unstructured":"Ntelis K, Solomou EE, Sakkas L, Liossis SN, Daoussis D (2017) The role of platelets in autoimmunity, vasculopathy, and fibrosis: Implications for systemic sclerosis. Semin Arthritis Rheum 47:409\u2013417. https:\/\/doi.org\/10.1016\/j.semarthrit.2017.05.004","journal-title":"Semin Arthritis Rheum."},{"key":"8889_CR75","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/s0190-9622(80)80396-3","volume":"2","author":"R Fleischmajer","year":"1980","unstructured":"Fleischmajer R, Perlish JS (1980) Capillary alterations in scleroderma. J Am Acad Dermatol 2:161\u2013170. https:\/\/doi.org\/10.1016\/s0190-9622(80)80396-3","journal-title":"J Am Acad Dermatol."},{"key":"8889_CR76","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/00005792-198011000-00001","volume":"59","author":"GP Rodnan","year":"1980","unstructured":"Rodnan GP, Myerowitz RL, Justh GO (1980) Morphologic changes in the digital arteries of patients with progressive systemic sclerosis (scleroderma) and Raynaud phenomenon. Medicine (Baltimore) 59:393\u2013408. https:\/\/doi.org\/10.1097\/00005792-198011000-00001","journal-title":"Medicine (Baltimore)."},{"key":"8889_CR77","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/annrheumdis-2016-210229","volume":"76","author":"M Manetti","year":"2017","unstructured":"Manetti M, Romano E, Rosa I, Guiducci S, Bellando-Randone S, De Paulis A, Ibba-Manneschi L, Matucci-Cerinic M (2017) Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis. Ann Rheum Dis 76:924\u2013934. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210229","journal-title":"Ann Rheum Dis."},{"key":"8889_CR78","doi-asserted-by":"publisher","first-page":"R115","DOI":"10.1186\/ar2002","volume":"8","author":"B Giusti","year":"2006","unstructured":"Giusti B, Fibbi G, Margheri F, Serrat\u00ec S, Rossi L, Poggi F, Lapini I, Magi A, Del Rosso A, Cinelli M, Guiducci S, Kahaleh B, Bazzichi L, Bombardieri S, Matucci-Cerinic M, Gensini GF, Del Rosso M, Abbate R (2006) A model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients. Arthritis Res Ther 8:R115. https:\/\/doi.org\/10.1186\/ar2002","journal-title":"Arthritis Res Ther."},{"key":"8889_CR79","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1161\/circresaha.111.242057","volume":"109","author":"M Manetti","year":"2011","unstructured":"Manetti M, Guiducci S, Romano E, Ceccarelli C, Bellando-Randone S, Conforti ML, Ibba-Manneschi L, Matucci-Cerinic M (2011) Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis. Circ Res 109:e14-26. https:\/\/doi.org\/10.1161\/circresaha.111.242057","journal-title":"Circ Res."},{"key":"8889_CR80","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.autrev.2017.05.024","volume":"16","author":"Y Mostmans","year":"2017","unstructured":"Mostmans Y, Cutolo M, Giddelo C, Decuman S, Melsens K, Declercq H, Vandecasteele E, De Keyser F, Distler O, Gutermuth J, Smith V (2017) The role of endothelial cells in the vasculopathy of systemic sclerosis: A systematic review. Autoimmun Rev 16:774\u2013786. https:\/\/doi.org\/10.1016\/j.autrev.2017.05.024","journal-title":"Autoimmun Rev."},{"key":"8889_CR81","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/exd.12602","volume":"24","author":"R Saigusa","year":"2015","unstructured":"Saigusa R, Asano Y, Taniguchi T, Yamashita T, Takahashi T, Ichimura Y, Toyama T, Tamaki Z, Tada Y, Sugaya M, Kadono T, Sato S (2015) A possible contribution of endothelial CCN1 downregulation due to Fli1 deficiency to the development of digital ulcers in systemic sclerosis. Exp Dermatol 24:127\u2013132. https:\/\/doi.org\/10.1111\/exd.12602","journal-title":"Exp Dermatol."},{"key":"8889_CR82","doi-asserted-by":"publisher","unstructured":"Truchetet ME, Demoures B, Eduardo Guimaraes J, Bertrand A, Laurent P, Jolivel V, Douchet I, Jacquemin C, Khoryati L, Duffau P, Lazaro E, Richez C, Seneschal J, Doutre MS, Pellegrin JL, Constans J, Schaeverbeke T, Blanco P, Contin-Bordes C (2016) Platelets Induce Thymic Stromal Lymphopoietin Production by Endothelial Cells:Contribution to Fibrosis in Human Systemic Sclerosis. Arthritis & rheumatology. 68:2784\u20132794. https:\/\/doi.org\/10.1002\/art.39817","DOI":"10.1002\/art.39817"},{"key":"8889_CR83","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1182\/blood-2009-02-203372","volume":"114","author":"Y-S Choi","year":"2009","unstructured":"Choi Y-S, Choi H-J, Min J-K, Pyun B-J, Maeng Y-S, Park H, Kim J, Kim Y-M, Kwon Y-G (2009) Interleukin-33 induces angiogenesis and vascular permeability through ST2\/TRAF6-mediated endothelial nitric oxide production. Blood 114:3117\u20133126. https:\/\/doi.org\/10.1182\/blood-2009-02-203372","journal-title":"Blood."},{"key":"8889_CR84","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1136\/ard.2009.119321","volume":"69","author":"M Manetti","year":"2010","unstructured":"Manetti M, Ibba-Manneschi L, Liakouli V, Guiducci S, Milia AF, Benelli G, Marrelli A, Conforti ML, Romano E, Giacomelli R, Matucci-Cerinic M, Cipriani P (2010) The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis. Ann Rheum Dis 69:598\u2013605. https:\/\/doi.org\/10.1136\/ard.2009.119321","journal-title":"Ann Rheum Dis."},{"key":"8889_CR85","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s10875-014-0037-0","volume":"34","author":"S Vettori","year":"2014","unstructured":"Vettori S, Cuomo G, Iudici M, D\u2019Abrosca V, Giacco V, Barra G, De Palma R, Valentini G (2014) Early systemic sclerosis: serum profiling of factors involved in endothelial, T-cell, and fibroblast interplay is marked by elevated interleukin-33 levels. J Clin Immunol 34:663\u2013668. https:\/\/doi.org\/10.1007\/s10875-014-0037-0","journal-title":"J Clin Immunol."},{"key":"8889_CR86","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00393-016-0202-3","volume":"77","author":"YJ Zhang","year":"2018","unstructured":"Zhang YJ, Zhang Q, Yang GJ, Tao JH, Wu GC, Huang XL, Duan Y, Li XP, Ye DQ, Wang J (2018) Elevated serum levels of interleukin-1\u03b2 and interleukin-33 in patients with systemic sclerosis in Chinese population. Z Rheumatol 77:151\u2013159. https:\/\/doi.org\/10.1007\/s00393-016-0202-3","journal-title":"Z Rheumatol."},{"key":"8889_CR87","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nri1412","volume":"4","author":"TA Wynn","year":"2004","unstructured":"Wynn TA (2004) Fibrotic disease and the T(H)1\/T(H)2 paradigm. Nat Rev Immunol 4:583\u2013594","journal-title":"Nat Rev Immunol."},{"key":"8889_CR88","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1146\/annurev-pathol-020712-163930","volume":"8","author":"JS Duffield","year":"2013","unstructured":"Duffield JS, Lupher M, Thannickal VJ, Wynn TA (2013) Host responses in tissue repair and fibrosis. Ann Rev Pathol 8:241\u2013276. https:\/\/doi.org\/10.1146\/annurev-pathol-020712-163930","journal-title":"Annual review of pathology."},{"key":"8889_CR89","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nri.2017.90","volume":"18","author":"RL Gieseck 3rd","year":"2018","unstructured":"Gieseck RL 3rd, Wilson MS, Wynn TA (2018) Type 2 immunity in tissue repair and fibrosis. Nat Rev Immunol 18:62\u201376. https:\/\/doi.org\/10.1038\/nri.2017.90","journal-title":"Nat Rev Immunol."},{"key":"8889_CR90","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s00281-015-0509-1","volume":"37","author":"C Chizzolini","year":"2015","unstructured":"Chizzolini C, Boin F (2015) The role of the acquired immune response in systemic sclerosis. Semin Immunopathol 37:519\u2013528. https:\/\/doi.org\/10.1007\/s00281-015-0509-1","journal-title":"Semin Immunopathol."},{"key":"8889_CR91","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","volume":"587","author":"NC Henderson","year":"2020","unstructured":"Henderson NC, Rieder F, Wynn TA (2020) Fibrosis: from mechanisms to medicines. Nature 587:555\u2013566. https:\/\/doi.org\/10.1038\/s41586-020-2938-9","journal-title":"Nature."},{"key":"8889_CR92","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/nrrheum.2009.26","volume":"5","author":"J Varga","year":"2009","unstructured":"Varga J, Pasche B (2009) Transforming growth factor \u03b2 as a therapeutic target in systemic sclerosis. Nat Rev Rheumatol 5:200\u2013206. https:\/\/doi.org\/10.1038\/nrrheum.2009.26","journal-title":"Nature Reviews Rheumatology."},{"key":"8889_CR93","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190103","volume":"217","author":"N Frangogiannis","year":"2020","unstructured":"Frangogiannis N (2020) Transforming growth factor-\u03b2 in tissue fibrosis. J Exp Med 217:e20190103. https:\/\/doi.org\/10.1084\/jem.20190103","journal-title":"J Exp Med."},{"key":"8889_CR94","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.matbio.2017.12.016","volume":"68\u201369","author":"AH Gy\u00f6rfi","year":"2018","unstructured":"Gy\u00f6rfi AH, Matei AE, Distler JHW (2018) Targeting TGF-\u03b2 signaling for the treatment of fibrosis. Matrix Biol 68\u201369:8\u201327. https:\/\/doi.org\/10.1016\/j.matbio.2017.12.016","journal-title":"Matrix Biol."},{"key":"8889_CR95","doi-asserted-by":"publisher","first-page":"10715","DOI":"10.1074\/jbc.M511343200","volume":"281","author":"X Shi-wen","year":"2006","unstructured":"Shi-wen X, Stanton LA, Kennedy L, Pala D, Chen Y, Howat SL, Renzoni EA, Carter DE, Bou-Gharios G, Stratton RJ, Pearson JD, Beier F, Lyons KM, Black CM, Abraham DJ, Leask A (2006) CCN2 is necessary for adhesive responses to transforming growth factor-\u03b21 in embryonic fibroblasts*. J Biol Chem 281:10715\u201310726. https:\/\/doi.org\/10.1074\/jbc.M511343200","journal-title":"Journal of Biological Chemistry."},{"key":"8889_CR96","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41584-019-0322-7","volume":"15","author":"JHW Distler","year":"2019","unstructured":"Distler JHW, Gyorfi AH, Ramanujam M, Whitfield ML, Konigshoff M, Lafyatis R (2019) Shared and distinct mechanisms of fibrosis. Nat Rev Rheumatol 15:705\u2013730. https:\/\/doi.org\/10.1038\/s41584-019-0322-7","journal-title":"Nat Rev Rheumatol."},{"key":"8889_CR97","doi-asserted-by":"publisher","first-page":"12319","DOI":"10.1073\/pnas.1635114100","volume":"100","author":"ML Whitfield","year":"2003","unstructured":"Whitfield ML, Finlay DR, Murray JI, Troyanskaya OG, Chi JT, Pergamenschikov A, McCalmont TH, Brown PO, Botstein D, Connolly MK (2003) Systemic and cell type-specific gene expression patterns in scleroderma skin. Proc Natl Acad Sci U S A 100:12319\u201312324. https:\/\/doi.org\/10.1073\/pnas.1635114100","journal-title":"Proc Natl Acad Sci U S A."},{"key":"8889_CR98","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1038\/jid.2011.472","volume":"132","author":"SA Pendergrass","year":"2012","unstructured":"Pendergrass SA, Lemaire R, Francis IP, Mahoney JM, Lafyatis R, Whitfield ML (2012) Intrinsic gene expression subsets of diffuse cutaneous systemic sclerosis are stable in serial skin biopsies. J Invest Dermatol 132:1363\u20131373. https:\/\/doi.org\/10.1038\/jid.2011.472","journal-title":"J Invest Dermatol."},{"key":"8889_CR99","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.89073","volume":"1","author":"S Lofgren","year":"2016","unstructured":"Lofgren S, Hinchcliff M, Carns M, Wood T, Aren K, Arroyo E, Cheung P, Kuo A, Valenzuela A, Haemel A, Wolters PJ, Gordon J, Spiera R, Assassi S, Boin F, Chung L, Fiorentino D, Utz PJ, Whitfield ML, Khatri P (2016) Integrated, multicohort analysis of systemic sclerosis identifies robust transcriptional signature of disease severity. JCI Insight 1:e89073. https:\/\/doi.org\/10.1172\/jci.insight.89073","journal-title":"JCI insight."},{"key":"8889_CR100","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/art.40898","volume":"71","author":"JM Franks","year":"2019","unstructured":"Franks JM, Martyanov V, Cai G, Wang Y, Li Z, Wood TA, Whitfield ML (2019) A machine learning classifier for assigning individual patients with systemic sclerosis to intrinsic molecular subsets. Arthritis Rheumatol 71:1701\u20131710. https:\/\/doi.org\/10.1002\/art.40898","journal-title":"Arthritis & rheumatology."},{"key":"8889_CR101","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S1357-2725(96)00115-X","volume":"29","author":"SE Mutsaers","year":"1997","unstructured":"Mutsaers SE, Bishop JE, McGrouther G, Laurent GJ (1997) Mechanisms of tissue repair: from wound healing to fibrosis. Int J Biochem Cell Biol 29:5\u201317","journal-title":"Int J Biochem Cell Biol."},{"key":"8889_CR102","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41584-019-0324-5","volume":"16","author":"B Hinz","year":"2020","unstructured":"Hinz B, Lagares D (2020) Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases. Nat Rev Rheumatol 16:11\u201331. https:\/\/doi.org\/10.1038\/s41584-019-0324-5","journal-title":"Nat Rev Rheumatol."},{"key":"8889_CR103","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/S0002-9440(10)61776-2","volume":"159","author":"B Hinz","year":"2001","unstructured":"Hinz B, Mastrangelo D, Iselin CE, Chaponnier C, Gabbiani G (2001) Mechanical tension controls granulation tissue contractile activity and myofibroblast differentiation. Am J Pathol 159:1009\u20131020. https:\/\/doi.org\/10.1016\/S0002-9440(10)61776-2","journal-title":"Am J Pathol."},{"key":"8889_CR104","doi-asserted-by":"publisher","unstructured":"Bhattacharyya S, Tamaki Z, Wang W, Hinchcliff M, Hoover P, Getsios S, White ES, Varga J (2014) FibronectinEDA promotes chronic cutaneous fibrosis through Toll-like receptor signaling. Sci Transl Med 6:232ra250.\u00a0https:\/\/doi.org\/10.1126\/scitranslmed.3008264","DOI":"10.1126\/scitranslmed.3008264"},{"key":"8889_CR105","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1172\/jci93555","volume":"128","author":"MD Lynch","year":"2018","unstructured":"Lynch MD, Watt FM (2018) Fibroblast heterogeneity: implications for human disease. J Clin Invest 128:26\u201335. https:\/\/doi.org\/10.1172\/jci93555","journal-title":"J Clin Invest."},{"key":"8889_CR106","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1016\/j.celrep.2018.03.010","volume":"22","author":"T Xie","year":"2018","unstructured":"Xie T, Wang Y, Deng N, Huang G, Taghavifar F, Geng Y, Liu N, Kulur V, Yao C, Chen P, Liu Z, Stripp B, Tang J, Liang J, Noble PW, Jiang D (2018) Single-Cell Deconvolution of fibroblast heterogeneity in mouse pulmonary fibrosis. Cell Rep 22:3625\u20133640. https:\/\/doi.org\/10.1016\/j.celrep.2018.03.010","journal-title":"Cell Rep."},{"key":"8889_CR107","doi-asserted-by":"publisher","unstructured":"Griffin MF,\u00a0desJardins-Park HE, Mascharak S, Borrelli MR, Longaker MT (2020) Understanding the impact of fibroblast heterogeneity on skin fibrosis. Dis Models Mech 13 https:\/\/doi.org\/10.1242\/dmm.044164","DOI":"10.1242\/dmm.044164"},{"key":"8889_CR108","first-page":"131","volume":"66","author":"G Gabbiani","year":"1972","unstructured":"Gabbiani G, Majno G (1972) Dupuytren\u2019s contracture: fibroblast contraction? An ultrastructural study. Am J Pathol 66:131\u2013146","journal-title":"An ultrastructural study. Am J Pathol."},{"key":"8889_CR109","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.2353\/ajpath.2007.070112","volume":"170","author":"B Hinz","year":"2007","unstructured":"Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML, Gabbiani G (2007) The myofibroblast: one function, multiple origins. Am J Pathol 170:1807\u20131816. https:\/\/doi.org\/10.2353\/ajpath.2007.070112","journal-title":"Am J Pathol."},{"key":"8889_CR110","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.ajpath.2012.02.004","volume":"180","author":"B Hinz","year":"2012","unstructured":"Hinz B, Phan SH, Thannickal VJ, Prunotto M, Desmouliere A, Varga J, De Wever O, Mareel M, Gabbiani G (2012) Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am J Pathol 180:1340\u20131355. https:\/\/doi.org\/10.1016\/j.ajpath.2012.02.004","journal-title":"Am J Pathol."},{"key":"8889_CR111","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3389\/fimmu.2020.00648","volume":"11","author":"B Russo","year":"2020","unstructured":"Russo B, Brembilla NC, Chizzolini C (2020) Interplay between keratinocytes and fibroblasts: a systematic review providing a new angle for understanding skin fibrotic disorders. Front Immunol 11:648. https:\/\/doi.org\/10.3389\/fimmu.2020.00648","journal-title":"Frontiers in immunology."},{"key":"8889_CR112","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/rheumatology\/ken370","volume":"47","author":"N Aden","year":"2008","unstructured":"Aden N, Shiwen X, Aden D, Black C, Nuttall A, Denton CP, Leask A, Abraham D, Stratton R (2008) Proteomic analysis of scleroderma lesional skin reveals activated wound healing phenotype of epidermal cell layer. Rheumatology (Oxford) 47:1754\u20131760. https:\/\/doi.org\/10.1093\/rheumatology\/ken370","journal-title":"Rheumatology (Oxford)."},{"key":"8889_CR113","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1038\/jid.2010.120","volume":"130","author":"N Aden","year":"2010","unstructured":"Aden N, Nuttall A, Shiwen X, de Winter P, Leask A, Black CM, Denton CP, Abraham DJ, Stratton RJ (2010) Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosis. J Invest Dermatol 130:2191\u20132200. https:\/\/doi.org\/10.1038\/jid.2010.120","journal-title":"J Invest Dermatol."},{"key":"8889_CR114","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/jid.2012.389","volume":"133","author":"J Canady","year":"2013","unstructured":"Canady J, Arndt S, Karrer S, Bosserhoff AK (2013) Increased KGF expression promotes fibroblast activation in a double paracrine manner resulting in cutaneous fibrosis. J Invest Dermatol 133:647\u2013657. https:\/\/doi.org\/10.1038\/jid.2012.389","journal-title":"J Invest Dermatol."},{"key":"8889_CR115","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1038\/jid.2014.253","volume":"134","author":"J Nikitorowicz-Buniak","year":"2014","unstructured":"Nikitorowicz-Buniak J, Shiwen X, Denton CP, Abraham D, Stratton R (2014) Abnormally differentiating keratinocytes in the epidermis of systemic sclerosis patients show enhanced secretion of CCN2 and S100A9. J Invest Dermatol 134:2693\u20132702. https:\/\/doi.org\/10.1038\/jid.2014.253","journal-title":"J Invest Dermatol."},{"key":"8889_CR116","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1093\/rheumatology\/kex280","volume":"56","author":"SS McCoy","year":"2017","unstructured":"McCoy SS, Reed TJ, Berthier CC, Tsou PS, Liu J, Gudjonsson JE, Khanna D, Kahlenberg JM (2017) Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta. Rheumatology (Oxford) 56:1970\u20131981. https:\/\/doi.org\/10.1093\/rheumatology\/kex280","journal-title":"Rheumatology (Oxford)."},{"key":"8889_CR117","doi-asserted-by":"publisher","unstructured":"Russo B, Borowczyk J, Boehncke WH, Truchetet ME, Modarressi A, Brembilla NC, Chizzolini C (2021) Dysfunctional keratinocytes increase dermal inflammation in systemic sclerosis. Results from tissue-engineered scleroderma epidermis. Arthritis Rheumatol.\u00a0https:\/\/doi.org\/10.1002\/art.41659","DOI":"10.1002\/art.41659"},{"key":"8889_CR118","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1084\/jem.20160247","volume":"214","author":"T Takahashi","year":"2017","unstructured":"Takahashi T, Asano Y, Sugawara K, Yamashita T, Nakamura K, Saigusa R, Ichimura Y, Toyama T, Taniguchi T, Akamata K, Noda S, Yoshizaki A, Tsuruta D, Trojanowska M, Sato S (2017) Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: Possible roles in scleroderma. J Exp Med 214:1129\u20131151. https:\/\/doi.org\/10.1084\/jem.20160247","journal-title":"J Exp Med."},{"key":"8889_CR119","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1136\/annrheumdis-2015-207477","volume":"75","author":"NC Brembilla","year":"2016","unstructured":"Brembilla NC, Dufour AM, Alvarez M, Hugues S, Montanari E, Truchetet ME, Lonati P, Fontao L, Gabrielli A, Vettori S, Valentini G, Boehncke WH, Meroni P, Chizzolini C (2016) IL-22 capacitates dermal fibroblast responses to TNF in scleroderma. Ann Rheum Dis 75:1697\u20131705. https:\/\/doi.org\/10.1136\/annrheumdis-2015-207477","journal-title":"Ann Rheum Dis."},{"key":"8889_CR120","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jid.2019.05.026","volume":"140","author":"AM Dufour","year":"2020","unstructured":"Dufour AM, Borowczyk-Michalowska J, Alvarez M, Truchetet ME, Modarressi A, Brembilla NC, Chizzolini C (2020) IL-17A dissociates inflammation from fibrogenesis in systemic sclerosis (scleroderma). J Invest Dermatol 140:103\u2013112. https:\/\/doi.org\/10.1016\/j.jid.2019.05.026","journal-title":"J Invest Dermatol."},{"key":"8889_CR121","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1172\/JCI118071","volume":"96","author":"M Kuwana","year":"1995","unstructured":"Kuwana M, Medsger TA Jr, Wright TM (1995) T cell proliferative response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donors. J Clin Invest 96:586\u2013596","journal-title":"J Clin Invest."},{"key":"8889_CR122","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13075-016-0993-2","volume":"18","author":"A Fava","year":"2016","unstructured":"Fava A, Cimbro R, Wigley FM, Liu QR, Rosen A, Boin F (2016) Frequency of circulating topoisomerase-I-specific CD4 T cells predicts presence and progression of interstitial lung disease in scleroderma. Arthritis Res Ther 18:99. https:\/\/doi.org\/10.1186\/s13075-016-0993-2","journal-title":"Arthritis Res Ther."},{"key":"8889_CR123","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.4049\/jimmunol.168.7.3649","volume":"168","author":"LI Sakkas","year":"2002","unstructured":"Sakkas LI, Xu B, Artlett CM, Lu S, Jimenez SA, Platsoucas CD (2002) Oligoclonal T cell expansion in the skin of patients with systemic sclerosis. J Immunol 168:3649\u20133659","journal-title":"J Immunol."},{"key":"8889_CR124","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S0140-6736(11)60982-3","volume":"378","author":"RK Burt","year":"2011","unstructured":"Burt RK, Shah SJ, Dill K, Grant T, Gheorghiade M, Schroeder J, Craig R, Hirano I, Marshall K, Ruderman E, Jovanovic B, Milanetti F, Jain S, Boyce K, Morgan A, Carr J, Barr W (2011) Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial. Lancet 378:498\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(11)60982-3","journal-title":"Lancet."},{"key":"8889_CR125","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1001\/jama.2014.6368","volume":"311","author":"JM van Laar","year":"2014","unstructured":"van Laar JM, Farge D, Sont JK, Naraghi K, Marjanovic Z, Larghero J, Schuerwegh AJ, Marijt EW, Vonk MC, Schattenberg AV, Matucci-Cerinic M, Voskuyl AE, van de Loosdrecht AA, Daikeler T, Kotter I, Schmalzing M, Martin T, Lioure B, Weiner SM, Kreuter A, Deligny C, Durand JM, Emery P, Machold KP, Sarrot-Reynauld F, Warnatz K, Adoue DF, Constans J, Tony HP, Del Papa N, Fassas A, Himsel A, Launay D, Lo Monaco A, Philippe P, Quere I, Rich E, Westhovens R, Griffiths B, Saccardi R, van den Hoogen FH, Fibbe WE, Socie G, Gratwohl A, Tyndall A (2014) Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial. JAMA\u202fJ Am Med Assoc 311:2490\u20132498. https:\/\/doi.org\/10.1001\/jama.2014.6368","journal-title":"JAMA : the journal of the American Medical Association."},{"key":"8889_CR126","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa1703327","volume":"378","author":"KM Sullivan","year":"2018","unstructured":"Sullivan KM, Goldmuntz EA, Keyes-Elstein L, McSweeney PA, Pinckney A, Welch B, Mayes MD, Nash RA, Crofford LJ, Eggleston B, Castina S, Griffith LM, Goldstein JS, Wallace D, Craciunescu O, Khanna D, Folz RJ, Goldin J, St Clair EW, Seibold JR, Phillips K, Mineishi S, Simms RW, Ballen K, Wener MH, Georges GE, Heimfeld S, Hosing C, Forman S, Kafaja S, Silver RM, Griffing L, Storek J, LeClercq S, Brasington R, Csuka ME, Bredeson C, Keever-Taylor C, Domsic RT, Kahaleh MB, Medsger T, Furst DE (2018) Myeloablative autologous stem-cell transplantation for severe scleroderma. N Engl J Med 378:35\u201347","journal-title":"N Engl J Med."},{"key":"8889_CR127","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1002\/art.30539","volume":"63","author":"A Yoshizaki","year":"2011","unstructured":"Yoshizaki A, Yanaba K, Ogawa A, Asano Y, Kadono T, Sato S (2011) Immunization with DNA topoisomerase I and Freund\u2019s complete adjuvant induces skin and lung fibrosis and autoimmunity via interleukin-6 signaling. Arthritis Rheum 63:3575\u20133585. https:\/\/doi.org\/10.1002\/art.30539","journal-title":"Arthritis Rheum."},{"key":"8889_CR128","first-page":"2243","volume":"34","author":"PQ Hu","year":"2007","unstructured":"Hu PQ, Hurwitz AA, Oppenheim JJ (2007) Immunization with DNA topoisomerase I induces autoimmune responses but not scleroderma-like pathologies in mice. J Rheumatol 34:2243\u20132252","journal-title":"J Rheumatol."},{"key":"8889_CR129","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.pharmthera.2018.08.003","volume":"192","author":"J Henderson","year":"2018","unstructured":"Henderson J, Bhattacharyya S, Varga J, O\u2019Reilly S (2018) Targeting TLRs and the inflammasome in systemic sclerosis. Pharmacol Ther 192:163\u2013169. https:\/\/doi.org\/10.1016\/j.pharmthera.2018.08.003","journal-title":"Pharmacology & therapeutics."},{"key":"8889_CR130","doi-asserted-by":"publisher","first-page":"R136","DOI":"10.1186\/ar4598","volume":"16","author":"G Stifano","year":"2014","unstructured":"Stifano G, Affandi AJ, Mathes AL, Rice LM, Nakerakanti S, Nazari B, Lee J, Christmann RB, Lafyatis R (2014) Chronic Toll-like receptor 4 stimulation in skin induces inflammation, macrophage activation, transforming growth factor beta signature gene expression, and fibrosis. Arthritis Res Ther 16:R136. https:\/\/doi.org\/10.1186\/ar4598","journal-title":"Arthritis Res Ther."},{"key":"8889_CR131","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/art.38901","volume":"67","author":"T Takahashi","year":"2015","unstructured":"Takahashi T, Asano Y, Ichimura Y, Toyama T, Taniguchi T, Noda S, Akamata K, Tada Y, Sugaya M, Kadono T, Sato S (2015) Amelioration of tissue fibrosis by toll-like receptor 4 knockout in murine models of systemic sclerosis. Arthritis Rheumatol 67:254\u2013265. https:\/\/doi.org\/10.1002\/art.38901","journal-title":"Arthritis & rheumatology."},{"key":"8889_CR132","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13075-017-1237-9","volume":"19","author":"A Farina","year":"2017","unstructured":"Farina A, Peruzzi G, Lacconi V, Lenna S, Quarta S, Rosato E, Vestri AR, York M, Dreyfus DH, Faggioni A, Morrone S, Trojanowska M, Farina GA (2017) Epstein-Barr virus lytic infection promotes activation of Toll-like receptor 8 innate immune response in systemic sclerosis monocytes. Arthritis Res Ther 19:39. https:\/\/doi.org\/10.1186\/s13075-017-1237-9","journal-title":"Arthritis Res Ther."},{"key":"8889_CR133","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1136\/annrheumdis-2012-201958","volume":"72","author":"M Ciechomska","year":"2013","unstructured":"Ciechomska M, Huigens CA, Hugle T, Stanly T, Gessner A, Griffiths B, Radstake TR, Hambleton S, O\u2019Reilly S, van Laar JM (2013) Toll-like receptor-mediated, enhanced production of profibrotic TIMP-1 in monocytes from patients with systemic sclerosis: role of serum factors. Ann Rheum Dis 72:1382\u20131389. https:\/\/doi.org\/10.1136\/annrheumdis-2012-201958","journal-title":"Ann Rheum Dis."},{"key":"8889_CR134","doi-asserted-by":"publisher","unstructured":"Kioon MDA, Tripodo C, Fernandez D, Kirou KA, Spiera RF, Crow MK, Gordon JK, Barrat FJ (2018) Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8. Sci Transl Med 10.\u00a0https:\/\/doi.org\/10.1126\/scitranslmed.aam8458","DOI":"10.1126\/scitranslmed.aam8458"},{"key":"8889_CR135","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1136\/ard.2009.121400","volume":"69","author":"ML Eloranta","year":"2010","unstructured":"Eloranta ML, Franck-Larsson K, Lovgren T, Kalamajski S, Ronnblom A, Rubin K, Alm GV, Ronnblom L (2010) Type I interferon system activation and association with disease manifestations in systemic sclerosis. Ann Rheum Dis 69:1396\u20131402. https:\/\/doi.org\/10.1136\/ard.2009.121400","journal-title":"Ann Rheum Dis."},{"key":"8889_CR136","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1038\/s41467-019-09683-z","volume":"10","author":"R Lande","year":"2019","unstructured":"Lande R, Lee EY, Palazzo R, Marinari B, Pietraforte I, Santos GS, Mattenberger Y, Spadaro F, Stefanantoni K, Iannace N, Dufour AM, Falchi M, Bianco M, Botti E, Bianchi L, Alvarez M, Riccieri V, Truchetet ME, G CLW, Chizzolini C, Frasca L, (2019) CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-alpha production in systemic sclerosis. Nat Commun 10:1731. https:\/\/doi.org\/10.1038\/s41467-019-09683-z","journal-title":"Nature communications."},{"key":"8889_CR137","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/art.41418","volume":"72","author":"C Ryu","year":"2020","unstructured":"Ryu C, Walia A, Ortiz V, Perry C, Woo S, Reeves BC, Sun H, Winkler J, Kanyo JE, Wang W, Vukmirovic M, Ristic N, Stratton EA, Meena SR, Minasyan M, Kurbanov D, Liu X, Lam TT, Farina G, Gomez JL, Gulati M, Herzog EL (2020) Bioactive plasma mitochondrial DNA is associated with disease progression in scleroderma-associated interstitial lung disease. Arthritis Rheumatol 72:1905\u20131915. https:\/\/doi.org\/10.1002\/art.41418","journal-title":"Arthritis & rheumatology."},{"key":"8889_CR138","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41584-019-0212-z","volume":"15","author":"G Kania","year":"2019","unstructured":"Kania G, Rudnik M, Distler O (2019) Involvement of the myeloid cell compartment in fibrogenesis and systemic sclerosis. Nat Rev Rheumatol 15:288\u2013302. https:\/\/doi.org\/10.1038\/s41584-019-0212-z","journal-title":"Nat Rev Rheumatol."},{"key":"8889_CR139","doi-asserted-by":"publisher","first-page":"5670","DOI":"10.1038\/s41467-019-13636-x","volume":"10","author":"M Jeljeli","year":"2019","unstructured":"Jeljeli M, Riccio LGC, Doridot L, Chene C, Nicco C, Chouzenoux S, Deletang Q, Allanore Y, Kavian N, Batteux F (2019) Trained immunity modulates inflammation-induced fibrosis. Nat Commun 10:5670. https:\/\/doi.org\/10.1038\/s41467-019-13636-x","journal-title":"Nature communications."},{"key":"8889_CR140","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1056\/NEJMoa1114576","volume":"370","author":"L van Bon","year":"2014","unstructured":"van Bon L, Affandi AJ, Broen J, Christmann RB, Marijnissen RJ, Stawski L, Farina GA, Stifano G, Mathes AL, Cossu M, York M, Collins C, Wenink M, Huijbens R, Hesselstrand R, Saxne T, DiMarzio M, Wuttge D, Agarwal SK, Reveille JD, Assassi S, Mayes M, Deng Y, Drenth JP, de Graaf J, den Heijer M, Kallenberg CG, Bijl M, Loof A, van den Berg WB, Joosten LA, Smith V, de Keyser F, Scorza R, Lunardi C, van Riel PL, Vonk M, van Heerde W, Meller S, Homey B, Beretta L, Roest M, Trojanowska M, Lafyatis R, Radstake TR (2014) Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis. N Engl J Med 370:433\u2013443. https:\/\/doi.org\/10.1056\/NEJMoa1114576","journal-title":"N Engl J Med."},{"key":"8889_CR141","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218439","author":"RL Ross","year":"2021","unstructured":"Ross RL, Corinaldesi C, Migneco G, Carr IM, Antanaviciute A, Wasson CW, Carriero A, Distler JHW, Holmes S, El-Sherbiny YM, McKimmie CS, Del Galdo F (2021) Targeting human plasmacytoid dendritic cells through BDCA2 prevents skin inflammation and fibrosis in a novel xenotransplant mouse model of scleroderma. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218439","journal-title":"Ann Rheum Dis"},{"key":"8889_CR142","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207388","author":"T Wohlfahrt","year":"2015","unstructured":"Wohlfahrt T, Usherenko S, Englbrecht M, Dees C, Weber S, Beyer C, Gelse K, Distler O, Schett G, Distler JH, Ramming A (2015) Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosis. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2015-207388","journal-title":"Ann Rheum Dis"},{"key":"8889_CR143","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-219748","author":"P Laurent","year":"2021","unstructured":"Laurent P, Allard B, Manicki P, Jolivel V, Levionnois E, Jeljeli M, Henrot P, Izotte J, Leleu D, Groppi A, Seneschal J, Constans J, Chizzolini C, Richez C, Duffau P, Lazaro E, Forcade E, Schaeverbeke T, Pradeu T, Batteux F, Blanco P, Contin-Bordes C, Truchetet ME (2021) TGF\u03b2 promotes low IL10-producing ILC2 with profibrotic ability involved in skin fibrosis in systemic sclerosis. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2020-219748","journal-title":"Ann Rheum Dis"},{"key":"8889_CR144","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1080\/14397595.2016.1206510","volume":"27","author":"JY Luo","year":"2017","unstructured":"Luo JY, Liu X, Jiang M, Zhao HP, Zhao JJ (2017) Oxidative stress markers in blood in systemic sclerosis: A meta-analysis. Mod Rheumatol 27:306\u2013314. https:\/\/doi.org\/10.1080\/14397595.2016.1206510","journal-title":"Mod Rheumatol."},{"key":"8889_CR145","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/cr.2013.75","volume":"23","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Choksi S, Chen K, Pobezinskaya Y, Linnoila I, Liu ZG (2013) ROS play a critical role in the differentiation of alternatively activated macrophages and the occurrence of tumor-associated macrophages. Cell Res 23:898\u2013914. https:\/\/doi.org\/10.1038\/cr.2013.75","journal-title":"Cell Res."},{"key":"8889_CR146","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1002\/art.39084","volume":"67","author":"T Spadoni","year":"2015","unstructured":"Spadoni T, Svegliati Baroni S, Amico D, Albani L, Moroncini G, Avvedimento EV, Gabrielli A (2015) A reactive oxygen species-mediated loop maintains increased expression of NADPH oxidases 2 and 4 in skin fibroblasts from patients with systemic sclerosis. Arthritis Rheumatol 67:1611\u20131622. https:\/\/doi.org\/10.1002\/art.39084","journal-title":"Arthritis & rheumatology."},{"key":"8889_CR147","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13075-017-1331-z","volume":"19","author":"CM Artlett","year":"2017","unstructured":"Artlett CM, Sassi-Gaha S, Hope JL, Feghali-Bostwick CA, Katsikis PD (2017) Mir-155 is overexpressed in systemic sclerosis fibroblasts and is required for NLRP3 inflammasome-mediated collagen synthesis during fibrosis. Arthritis Res Ther 19:144. https:\/\/doi.org\/10.1186\/s13075-017-1331-z","journal-title":"Arthritis Res Ther."},{"key":"8889_CR148","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.1002\/art.30568","volume":"63","author":"CM Artlett","year":"2011","unstructured":"Artlett CM, Sassi-Gaha S, Rieger JL, Boesteanu AC, Feghali-Bostwick CA, Katsikis PD (2011) The inflammasome activating caspase 1 mediates fibrosis and myofibroblast differentiation in systemic sclerosis. Arthritis Rheum 63:3563\u20133574. https:\/\/doi.org\/10.1002\/art.30568","journal-title":"Arthritis Rheum."},{"key":"8889_CR149","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s13075-017-1420-z","volume":"19","author":"J Henderson","year":"2017","unstructured":"Henderson J, O\u2019Reilly S (2017) Inflammasome lights up in systemic sclerosis. Arthritis Res Ther 19:205. https:\/\/doi.org\/10.1186\/s13075-017-1420-z","journal-title":"Arthritis Res Ther."},{"key":"8889_CR150","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1365-2362.1988.tb01158.x","volume":"18","author":"K Scharffetter","year":"1988","unstructured":"Scharffetter K, Lankat-Buttgereit B, Krieg T (1988) Localization of collagen mRNA in normal and scleroderma skin by in-situ hybridization. Eur J Clin Invest 18:9\u201317","journal-title":"Eur J Clin Invest."},{"key":"8889_CR151","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1136\/annrheumdis-2019-215894","volume":"79","author":"B Skaug","year":"2020","unstructured":"Skaug B, Khanna D, Swindell WR, Hinchcliff ME, Frech TM, Steen VD, Hant FN, Gordon JK, Shah AA, Zhu L, Zheng WJ, Browning JL, Barron AMS, Wu M, Visvanathan S, Baum P, Franks JM, Whitfield ML, Shanmugam VK, Domsic RT, Castelino FV, Bernstein EJ, Wareing N, Lyons MA, Ying J, Charles J, Mayes MD, Assassi S (2020) Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile. Ann Rheum Dis 79:379\u2013386. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215894","journal-title":"Ann Rheum Dis."},{"key":"8889_CR152","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/s41584-020-0404-6","volume":"16","author":"P Fuschiotti","year":"2020","unstructured":"Fuschiotti P (2020) T cells in SSc skin lesions: knowing your enemy. Nat Rev Rheumatol 16:253\u2013254. https:\/\/doi.org\/10.1038\/s41584-020-0404-6","journal-title":"Nat Rev Rheumatol."},{"key":"8889_CR153","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1084\/jem.194.6.809","volume":"194","author":"CG Lee","year":"2001","unstructured":"Lee CG, Homer RJ, Zhu Z, Lanone S, Wang X, Koteliansky V, Shipley JM, Gotwals P, Noble P, Chen Q, Senior RM, Elias JA (2001) Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J Exp Med 194:809\u2013821","journal-title":"J Exp Med."},{"key":"8889_CR154","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1002\/1529-0131(199811)41:11<2039::AID-ART20>3.0.CO;2-1","volume":"41","author":"C Chizzolini","year":"1998","unstructured":"Chizzolini C, Rezzonico R, Ribbens C, Burger D, Wollheim FA, Dayer JM (1998) Inhibition of type I collagen production by dermal fibroblasts upon contact with activated T cells: different sensitivity to inhibition between systemic sclerosis and control fibroblasts. Arthritis Rheum 41:2039\u20132047","journal-title":"Arthritis Rheum."},{"key":"8889_CR155","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/art.37860","volume":"65","author":"ME Truchetet","year":"2013","unstructured":"Truchetet ME, Brembilla NC, Montanari E, Lonati P, Raschi E, Zeni S, Fontao L, Meroni PL, Chizzolini C (2013) Interleukin-17A+ cell counts are increased in systemic sclerosis skin and their number is inversely correlated with the extent of skin involvement. Arthritis Rheum 65:1347\u20131356. https:\/\/doi.org\/10.1002\/art.37860","journal-title":"Arthritis Rheum."},{"key":"8889_CR156","doi-asserted-by":"publisher","unstructured":"Taylor DK, Mittereder N, Kuta E, Delaney T, Burwell T, Dacosta K, Zhao W, Cheng LI, Brown C, Boutrin A, Guo X, White WI, Zhu J, Dong H, Bowen MA, Lin J, Gao C, Yu L, Ramaswamy M, Gaudreau MC, Woods R, Herbst R, Carlesso G (2018) T follicular helper-like cells contribute to skin fibrosis. Sci Transl Med 10.\u00a0https:\/\/doi.org\/10.1126\/scitranslmed.aaf5307","DOI":"10.1126\/scitranslmed.aaf5307"},{"key":"8889_CR157","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1136\/annrheumdis-2018-214382","volume":"78","author":"L Ricard","year":"2019","unstructured":"Ricard L, Jachiet V, Malard F, Ye Y, Stocker N, Riviere S, Senet P, Monfort JB, Fain O, Mohty M, Gaugler B, Mekinian A (2019) Circulating follicular helper T cells are increased in systemic sclerosis and promote plasmablast differentiation through the IL-21 pathway which can be inhibited by ruxolitinib. Ann Rheum Dis 78:539\u2013550. https:\/\/doi.org\/10.1136\/annrheumdis-2018-214382","journal-title":"Ann Rheum Dis."},{"key":"8889_CR158","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1002\/art.22847","volume":"56","author":"R Lafyatis","year":"2007","unstructured":"Lafyatis R, O\u2019Hara C, Feghali-Bostwick CA, Matteson E (2007) B cell infiltration in systemic sclerosis-associated interstitial lung disease. Arthritis Rheum 56:3167\u20133168","journal-title":"Arthritis Rheum."},{"key":"8889_CR159","doi-asserted-by":"publisher","first-page":"R168","DOI":"10.1186\/ar4352","volume":"15","author":"A Francois","year":"2013","unstructured":"Francois A, Chatelus E, Wachsmann D, Sibilia J, Bahram S, Alsaleh G, Gottenberg JE (2013) B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis. Arthritis Res Ther 15:R168. https:\/\/doi.org\/10.1186\/ar4352","journal-title":"Arthritis Res Ther."},{"key":"8889_CR160","doi-asserted-by":"publisher","DOI":"10.1002\/art.39437","author":"A Mavropoulos","year":"2015","unstructured":"Mavropoulos A, Simopoulou T, Varna A, Liaskos C, Katsiari C, Bogdanos DP, Sakkas LI (2015) B regulatory cells are decreased and functionally impaired in patients with systemic sclerosis. Arthritis Rheumatol\u00a0https:\/\/doi.org\/10.1002\/art.39437","journal-title":"Arthritis & rheumatology"},{"key":"8889_CR161","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1046\/j.1523-1747.2003.12097.x","volume":"120","author":"S Sato","year":"2003","unstructured":"Sato S, Hayakawa I, Hasegawa M, Fujimoto M, Takehara K (2003) Function blocking autoantibodies against matrix metalloproteinase-1 in patients with systemic sclerosis. J Invest Dermatol 120:542\u2013547","journal-title":"J Invest Dermatol."},{"key":"8889_CR162","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/j.1365-2249.2004.02615.x","volume":"138","author":"C Nishijima","year":"2004","unstructured":"Nishijima C, Hayakawa I, Matsushita T, Komura K, Hasegawa M, Takehara K, Sato S (2004) Autoantibody against matrix metalloproteinase-3 in patients with systemic sclerosis. Clin Exp Immunol 138:357\u2013363","journal-title":"Clin Exp Immunol."},{"key":"8889_CR163","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1002\/art.39728","volume":"68","author":"MM Luchetti","year":"2016","unstructured":"Luchetti MM, Moroncini G, Jose Escamez M, Svegliati Baroni S, Spadoni T, Grieco A, Paolini C, Funaro A, Avvedimento EV, Larcher F, Del Rio M, Gabrielli A (2016) Induction of scleroderma fibrosis in skin-humanized mice by administration of anti-platelet-derived growth factor receptor agonistic autoantibodies. Arthritis Rheumatol 68:2263\u20132273. https:\/\/doi.org\/10.1002\/art.39728","journal-title":"Arthritis & rheumatology."},{"key":"8889_CR164","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.imlet.2017.10.007","volume":"195","author":"G Moroncini","year":"2018","unstructured":"Moroncini G, Svegliati Baroni S, Gabrielli A (2018) Agonistic antibodies in systemic sclerosis. Immunol Lett 195:83\u201387. https:\/\/doi.org\/10.1016\/j.imlet.2017.10.007","journal-title":"Immunol Lett."},{"key":"8889_CR165","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.clim.2015.05.014","volume":"159","author":"NW Palm","year":"2015","unstructured":"Palm NW, de Zoete MR, Flavell RA (2015) Immune-microbiota interactions in health and disease. Clin Immunol 159:122\u2013127. https:\/\/doi.org\/10.1016\/j.clim.2015.05.014","journal-title":"Clin Immunol."},{"key":"8889_CR166","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13075-019-1816-z","volume":"21","author":"ME Johnson","year":"2019","unstructured":"Johnson ME, Franks JM, Cai G, Mehta BK, Wood TA, Archambault K, Pioli PA, Simms RW, Orzechowski N, Arron S, Whitfield ML (2019) Microbiome dysbiosis is associated with disease duration and increased inflammatory gene expression in systemic sclerosis skin. Arthritis Res Ther 21:49. https:\/\/doi.org\/10.1186\/s13075-019-1816-z","journal-title":"Arthritis Res Ther."},{"key":"8889_CR167","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1002\/art.39572","volume":"68","author":"ER Volkmann","year":"2016","unstructured":"Volkmann ER, Chang YL, Barroso N, Furst DE, Clements PJ, Gorn AH, Roth BE, Conklin JL, Getzug T, Borneman J, McGovern DP, Tong M, Jacobs JP, Braun J (2016) Association of systemic sclerosis with a unique colonic microbial consortium. Arthritis Rheumatol 68:1483\u20131492. https:\/\/doi.org\/10.1002\/art.39572","journal-title":"Arthritis & rheumatology."},{"key":"8889_CR168","doi-asserted-by":"publisher","first-page":"14874","DOI":"10.1038\/s41598-017-14889-6","volume":"7","author":"V Patrone","year":"2017","unstructured":"Patrone V, Puglisi E, Cardinali M, Schnitzler TS, Svegliati S, Festa A, Gabrielli A, Morelli L (2017) Gut microbiota profile in systemic sclerosis patients with and without clinical evidence of gastrointestinal involvement. Sci Rep 7:14874. https:\/\/doi.org\/10.1038\/s41598-017-14889-6","journal-title":"Scientific reports."},{"key":"8889_CR169","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/nyas.13736","volume":"1421","author":"C Bellocchi","year":"2018","unstructured":"Bellocchi C, Fern\u00e1ndez-Ochoa \u00c1, Montanelli G, Vigone B, Santaniello A, Milani C, Quirantes-Pin\u00e9 R, Borr\u00e1s-Linares I, Ventura M, Segura-Carrettero A, Alarc\u00f3n-Riquelme ME, Beretta L (2018) Microbial and metabolic multi-omic correlations in systemic sclerosis patients. Ann N Y Acad Sci 1421:97\u2013109. https:\/\/doi.org\/10.1111\/nyas.13736","journal-title":"Ann N Y Acad Sci."},{"key":"8889_CR170","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13073-021-00853-7","volume":"13","author":"DR Plichta","year":"2021","unstructured":"Plichta DR, Somani J, Pichaud M, Wallace ZS, Fernandes AD, Perugino CA, L\u00e4hdesm\u00e4ki H, Stone JH, Vlamakis H, Chung DC, Khanna D, Pillai S, Xavier RJ (2021) Congruent microbiome signatures in fibrosis-prone autoimmune diseases: IgG4-related disease and systemic sclerosis. Genome Med 13:35. https:\/\/doi.org\/10.1186\/s13073-021-00853-7","journal-title":"Genome Medicine."},{"key":"8889_CR171","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002696","volume":"3","author":"A Milano","year":"2008","unstructured":"Milano A, Pendergrass SA, Sargent JL, George LK, McCalmont TH, Connolly MK, Whitfield ML (2008) Molecular subsets in the gene expression signatures of scleroderma skin. PLoS One 3:e2696. https:\/\/doi.org\/10.1371\/journal.pone.0002696","journal-title":"PLoS One."},{"key":"8889_CR172","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13075-017-1360-7","volume":"19","author":"EC Derrett-Smith","year":"2017","unstructured":"Derrett-Smith EC, Martyanov V, Chighizola CB, Moinzadeh P, Campochiaro C, Khan K, Wood TA, Meroni PL, Abraham DJ, Ong VH, Lafyatis R, Whitfield ML, Denton CP (2017) Limited cutaneous systemic sclerosis skin demonstrates distinct molecular subsets separated by a cardiovascular development gene expression signature. Arthritis Res Ther 19:156. https:\/\/doi.org\/10.1186\/s13075-017-1360-7","journal-title":"Arthritis Res Ther."},{"key":"8889_CR173","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1004005","volume":"11","author":"JM Mahoney","year":"2015","unstructured":"Mahoney JM, Taroni J, Martyanov V, Wood TA, Greene CS, Pioli PA, Hinchcliff ME, Whitfield ML (2015) Systems level analysis of systemic sclerosis shows a network of immune and profibrotic pathways connected with genetic polymorphisms. PLoS Comput Biol 11:e1004005. https:\/\/doi.org\/10.1371\/journal.pcbi.1004005","journal-title":"PLoS computational biology."},{"key":"8889_CR174","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13073-017-0417-1","volume":"9","author":"JN Taroni","year":"2017","unstructured":"Taroni JN, Greene CS, Martyanov V, Wood TA, Christmann RB, Farber HW, Lafyatis RA, Denton CP, Hinchcliff ME, Pioli PA, Mahoney JM, Whitfield ML (2017) A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis. Genome Med 9:27. https:\/\/doi.org\/10.1186\/s13073-017-0417-1","journal-title":"Genome Med."},{"key":"8889_CR175","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1002\/art.39289","volume":"67","author":"S Assassi","year":"2015","unstructured":"Assassi S, Swindell WR, Wu M, Tan FD, Khanna D, Furst DE, Tashkin DP, Jahan-Tigh RR, Mayes MD, Gudjonsson JE, Chang JT (2015) Dissecting the heterogeneity of skin gene expression patterns in systemic sclerosis. Arthritis Rheumatol 67:3016\u20133026. https:\/\/doi.org\/10.1002\/art.39289","journal-title":"Arthritis & rheumatology."},{"key":"8889_CR176","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1136\/annrheumdis-2018-214778","volume":"78","author":"SJ Moon","year":"2019","unstructured":"Moon SJ, Bae JM, Park KS, Tagkopoulos I, Kim KJ (2019) Compendium of skin molecular signatures identifies key pathological features associated with fibrosis in systemic sclerosis. Ann Rheum Dis 78:817\u2013825. https:\/\/doi.org\/10.1136\/annrheumdis-2018-214778","journal-title":"Ann Rheum Dis."},{"key":"8889_CR177","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1038\/jid.2013.130","volume":"133","author":"M Hinchcliff","year":"2013","unstructured":"Hinchcliff M, Huang CC, Wood TA, Matthew Mahoney J, Martyanov V, Bhattacharyya S, Tamaki Z, Lee J, Carns M, Podlusky S, Sirajuddin A, Shah SJ, Chang RW, Lafyatis R, Varga J, Whitfield ML (2013) Molecular signatures in skin associated with clinical improvement during mycophenolate treatment in systemic sclerosis. J Invest Dermatol 133:1979\u20131989. https:\/\/doi.org\/10.1038\/jid.2013.130","journal-title":"J Invest Dermatol."},{"key":"8889_CR178","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13075-015-0669-3","volume":"17","author":"EF Chakravarty","year":"2015","unstructured":"Chakravarty EF, Martyanov V, Fiorentino D, Wood TA, Haddon DJ, Jarrell JA, Utz PJ, Genovese MC, Whitfield ML, Chung L (2015) Gene expression changes reflect clinical response in a placebo-controlled randomized trial of abatacept in patients with diffuse cutaneous systemic sclerosis. Arthritis Res Ther 17:159. https:\/\/doi.org\/10.1186\/s13075-015-0669-3","journal-title":"Arthritis Res Ther."},{"key":"8889_CR179","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/art.41055","volume":"72","author":"D Khanna","year":"2020","unstructured":"Khanna D, Spino C, Johnson S, Chung L, Whitfield ML, Denton CP, Berrocal V, Franks J, Mehta B, Molitor J, Steen VD, Lafyatis R, Simms RW, Gill A, Kafaja S, Frech TM, Hsu V, Domsic RT, Pope JE, Gordon JK, Mayes MD, Schiopu E, Young A, Sandorfi N, Park J, Hant FN, Bernstein EJ, Chatterjee S, Castelino FV, Ajam A, Wang Y, Wood T, Allanore Y, Matucci-Cerinic M, Distler O, Singer O, Bush E, Fox DA, Furst DE (2020) Abatacept in early diffuse cutaneous systemic sclerosis: results of a Phase II investigator-initiated, multicenter, double-blind, randomized. placebo-controlled trial. Arthritis Rheumatol 72:125\u2013136. https:\/\/doi.org\/10.1002\/art.41055","journal-title":"Placebo-Controlled Trial. Arthritis & rheumatology."},{"key":"8889_CR180","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/art.24221","volume":"60","author":"L Chung","year":"2009","unstructured":"Chung L, Fiorentino DF, Benbarak MJ, Adler AS, Mariano MM, Paniagua RT, Milano A, Connolly MK, Ratiner BD, Wiskocil RL, Whitfield ML, Chang HY, Robinson WH (2009) Molecular framework for response to imatinib mesylate in systemic sclerosis. Arthritis Rheum 60:584\u2013591. https:\/\/doi.org\/10.1002\/art.24221","journal-title":"Arthritis Rheum."},{"key":"8889_CR181","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187580","volume":"12","author":"V Martyanov","year":"2017","unstructured":"Martyanov V, Kim GJ, Hayes W, Du S, Ganguly BJ, Sy O, Lee SK, Bogatkevich GS, Schieven GL, Schiopu E, Marangoni RG, Goldin J, Whitfield ML, Varga J (2017) Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease. PLoS One 12:e0187580. https:\/\/doi.org\/10.1371\/journal.pone.0187580","journal-title":"PLoS One."},{"key":"8889_CR182","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1136\/annrheumdis-2020-217033","volume":"79","author":"JM Franks","year":"2020","unstructured":"Franks JM, Martyanov V, Wang Y, Wood TA, Pinckney A, Crofford LJ, Keyes-Elstein L, Furst DE, Goldmuntz E, Mayes MD, McSweeney P, Nash RA, Sullivan KM, Whitfield ML (2020) Machine learning predicts stem cell transplant response in severe scleroderma. Ann Rheum Dis 79:1608\u20131615. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217033","journal-title":"Ann Rheum Dis."}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-021-08889-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-021-08889-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-021-08889-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T08:13:51Z","timestamp":1683706431000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-021-08889-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,6]]},"references-count":182,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["8889"],"URL":"https:\/\/doi.org\/10.1007\/s12016-021-08889-8","relation":{},"ISSN":["1559-0267"],"issn-type":[{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,6]]},"assertion":[{"value":"24 August 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}